Pharmabiz19d
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels
US FDA grants 510(k) clearance and CLIA waiver to Roche’s cobas liat sexually transmitted infection multiplex assay panels: Basel Thursday, January 23, 2025, 09:00 Hrs [IST] Roc ...
manilatimes20d
Roche receives FDA clearance with CLIA waiver for cobas® liat molecular tests to diagnose sexually transmitted infections at the point of care
More than 1 million curable sexually transmitted infections (STIs) are acquired every day worldwide in people 15-49 years old, most of which are asymptomatic.1 FDA CLIA-waived tests broaden access to ...
World Bank6y
Tanzania: Using Cash to Encourage Young Adults to Abstain from Risky Sexual Behavior
Trichomonas vaginalis and Mycoplasma genitalium) at periodic testing rounds (every four months for one year). Anyone testing positive was offered free treatment, and all received counselling. The ...